Found: 48
Select item for more details and to access through your institution.
Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 5, p. 1, doi. 10.1093/ofid/ofad187
- By:
- Publication type:
- Article
2718. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in US Adults Hospitalized with Pneumonia, 2014–2017.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S956, doi. 10.1093/ofid/ofz360.2395
- By:
- Publication type:
- Article
Recommending Higher Valent Pneumococcal Conjugate Vaccine for Older Adults—Reply.
- Published in:
- JAMA Internal Medicine, 2023, v. 183, n. 6, p. 624, doi. 10.1001/jamainternmed.2023.0551
- By:
- Publication type:
- Article
Association of Pneumococcal Conjugate Vaccine Use With Hospitalized Pneumonia in Medicare Beneficiaries 65 Years or Older With and Without Medical Conditions, 2014 to 2017.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years -- Increasing Community Access to Testing Program, United States, July 2022--February 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 7, p. 177, doi. 10.15585/mmwr.mm7207a3
- By:
- Publication type:
- Article
Laboratory-Confirmed COVID-19 Case Incidence Rates Among Residents in Nursing Homes by Up-to-Date Vaccination Status -- United States, October 10, 2022-January 8, 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 4, p. 95, doi. 10.15585/mmwr.mm7204a3
- By:
- Publication type:
- Article
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents -- 19 States, March 29-July 25, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 39, p. 1235, doi. 10.15585/mmwr.mm7139a2
- By:
- Publication type:
- Article
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant -- United States, February 14-March 27, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 18, p. 633
- By:
- Publication type:
- Article
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices -- United States, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 4, p. 109
- By:
- Publication type:
- Article
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Nasopharyngeal carriage of Streptococcus pneumoniae among children <5 years of age in Indonesia prior to pneumococcal conjugate vaccine introduction.
- Published in:
- PLoS ONE, 2024, v. 19, n. 1, p. 1, doi. 10.1371/journal.pone.0297041
- By:
- Publication type:
- Article
Postvaccine Genetic Structure of Streptococcus pneumoniae Serotype 19A from Children in the United States.
- Published in:
- Journal of Infectious Diseases, 2005, v. 192, n. 11, p. 1988
- By:
- Publication type:
- Article
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 1, p. 32, doi. 10.1086/648593
- By:
- Publication type:
- Article
Differential Effects of Pneumococcal Vaccines against Serotypes 6A and 6C.
- Published in:
- Journal of Infectious Diseases, 2008, v. 198, n. 12, p. 1818, doi. 10.1086/593339
- By:
- Publication type:
- Article
Population Snapshot of Emergent Streptococcus pneumoniae Serotype 19A in the United States, 2005.
- Published in:
- Journal of Infectious Diseases, 2008, v. 197, n. 7, p. 1016, doi. 10.1086/528996
- By:
- Publication type:
- Article
Genome-wide association analyses of invasive pneumococcal isolates identify a missense bacterial mutation associated with meningitis.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-07997-y
- By:
- Publication type:
- Article
Changing Epidemiology of Invasive Pneumococcal Disease Among Older Adults in the Era of Pediatric Pneumococcal Conjugate Vaccine.
- Published in:
- JAMA: Journal of the American Medical Association, 2005, v. 294, n. 16, p. 2043, doi. 10.1001/jama.294.16.2043
- By:
- Publication type:
- Article
Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults.
- Published in:
- Pathogens, 2023, v. 12, n. 5, p. 732, doi. 10.3390/pathogens12050732
- By:
- Publication type:
- Article
Corrigendum to: Effectiveness of the 7- and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-Serotype Otitis Media.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Effectiveness of the 7- and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-Serotype Otitis Media.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 4, p. 650, doi. 10.1093/cid/ciab066
- By:
- Publication type:
- Article
Invasive Pneumococcal Strain Distributions and Isolate Clusters Associated With Persons Experiencing Homelessness During 2018.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 12, p. e948, doi. 10.1093/cid/ciaa1680
- By:
- Publication type:
- Article
Early Impact of 13-Valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease Among Adults With and Without Underlying Medical Conditions—United States.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 12, p. 2484, doi. 10.1093/cid/ciz739
- By:
- Publication type:
- Article
Effectiveness of Six Improved Cookstoves in Reducing Household Air Pollution and Their Acceptability in Rural Western Kenya.
- Published in:
- PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0165529
- By:
- Publication type:
- Article
Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Relative Effectiveness of Coronavirus Disease 2019 Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Period—United States, 1 January 2022 to 31 March 2022
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 10, p. 1753, doi. 10.1093/cid/ciad063
- By:
- Publication type:
- Article
Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020–November 2021
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, p. S147, doi. 10.1093/cid/ciac562
- By:
- Publication type:
- Article
User Perspectives of Characteristics of Improved Cookstoves from a Field Evaluation in Western Kenya.
- Published in:
- International Journal of Environmental Research & Public Health, 2016, v. 13, n. 2, p. 167, doi. 10.3390/ijerph13020167
- By:
- Publication type:
- Article
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2014, v. 63, n. 37, p. 822
- By:
- Publication type:
- Article
Noninfluenza Vaccination Coverage Among Adults -- United States, 2012.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2014, v. 63, n. 5, p. 95
- By:
- Publication type:
- Article
Noninfluenza vaccination coverage among adults - United States, 2012.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6-18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2013, v. 62, n. 25, p. 521
- By:
- Publication type:
- Article
Noninfluenza Vaccination Coverage Among Adults -- United States, 2011.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2013, v. 62, n. 4, p. 66
- By:
- Publication type:
- Article
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2012, v. 61, n. 40, p. 816
- By:
- Publication type:
- Article
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2015, v. 64, n. 34, p. 944, doi. 10.15585/mmwr.mm6434a4
- By:
- Publication type:
- Article
Vaccination coverage among adults, excluding influenza vaccination - United States, 2013.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Vaccination Coverage Among Adults, Excluding Influenza Vaccination -- United States, 2013.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2015, v. 64, n. 4, p. 95
- By:
- Publication type:
- Article
ACIP Recommendations for PCV13 and PPSV23 Use.
- Published in:
- JAMA: Journal of the American Medical Association, 2013, v. 309, n. 4, p. 336
- By:
- Publication type:
- Article
Impact of Pneumococcal Conjugate Vaccines on Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in the United States.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Upsurge of Conjugate Vaccine Serotype 4 Invasive Pneumococcal Disease Clusters Among Adults Experiencing Homelessness in California, Colorado, and New Mexico.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effects of Pneumococcal Conjugate Vaccine in the United Kingdom: Success of Vaccine Policy and Remaining Opportunities for Prevention.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
A Population-Based Descriptive Atlas of Invasive Pneumococcal Strains Recovered Within the U.S. During 2015–2016.
- Published in:
- Frontiers in Microbiology, 2018, p. N.PAG, doi. 10.3389/fmicb.2018.02670
- By:
- Publication type:
- Article